707 related articles for article (PubMed ID: 28436744)
21. Performance of three cognitive screening tools in a sample of older New Zealanders.
Cheung G; Clugston A; Croucher M; Malone D; Mau E; Sims A; Gee S
Int Psychogeriatr; 2015 Jun; 27(6):981-9. PubMed ID: 25603424
[TBL] [Abstract][Full Text] [Related]
22. Validation of the Mini-Addenbrooke's Cognitive Examination in Mild Cognitive Impairment in Arabic Speakers.
Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Aly El-Gabry D; Abdel Aziz K; Saber HG
Dement Geriatr Cogn Disord; 2021; 50(2):178-182. PubMed ID: 34293741
[TBL] [Abstract][Full Text] [Related]
23. Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia.
Li X; Yang L; Yin J; Yu N; Ye F
J Clin Neurol; 2019 Jul; 15(3):313-320. PubMed ID: 31286702
[TBL] [Abstract][Full Text] [Related]
24. The Addenbrooke's Cognitive Examination Revised (ACE-R) and its sub-scores: normative values in an Italian population sample.
Siciliano M; Raimo S; Tufano D; Basile G; Grossi D; Santangelo F; Trojano L; Santangelo G
Neurol Sci; 2016 Mar; 37(3):385-92. PubMed ID: 26563847
[TBL] [Abstract][Full Text] [Related]
25. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke's Cognitive Examination-Revised (ACE-R) in a memory clinic-based population.
Hancock P; Larner AJ
Int Psychogeriatr; 2009 Jun; 21(3):526-30. PubMed ID: 19327203
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
[TBL] [Abstract][Full Text] [Related]
28. The validity of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in acute stroke.
Morris K; Hacker V; Lincoln NB
Disabil Rehabil; 2012; 34(3):189-95. PubMed ID: 21954948
[TBL] [Abstract][Full Text] [Related]
29. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity of the Mini-Mental State Examination, Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination III to everyday activity impairments in dementia: an exploratory study.
Giebel CM; Challis D
Int J Geriatr Psychiatry; 2017 Oct; 32(10):1085-1093. PubMed ID: 27593974
[TBL] [Abstract][Full Text] [Related]
31. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
Ozdilek B; Kenangil G
Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
[TBL] [Abstract][Full Text] [Related]
32. Applying ACE-III, M-ACE and MMSE to Diagnostic Screening Assessment of Cognitive Functions within the Polish Population.
Kaczmarek B; Ilkowska Z; Kropinska S; Tobis S; Krzyminska-Siemaszko R; Kaluzniak-Szymanowska A; Wieczorowska-Tobis K
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231581
[TBL] [Abstract][Full Text] [Related]
33. Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan.
Takenoshita S; Terada S; Yoshida H; Yamaguchi M; Yabe M; Imai N; Horiuchi M; Miki T; Yokota O; Yamada N
BMC Geriatr; 2019 Apr; 19(1):123. PubMed ID: 31035933
[TBL] [Abstract][Full Text] [Related]
34. Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.
Lucza T; Karádi K; Kállai J; Weintraut R; Janszky J; Makkos A; Komoly S; Kovács N
Behav Neurol; 2015; 2015():983606. PubMed ID: 26078489
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
Liew TM; Feng L; Gao Q; Ng TP; Yap P
J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
[TBL] [Abstract][Full Text] [Related]
36. Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment.
Fang R; Wang G; Huang Y; Zhuang JP; Tang HD; Wang Y; Deng YL; Xu W; Chen SD; Ren RJ
Dement Geriatr Cogn Disord; 2014; 37(3-4):223-31. PubMed ID: 24193223
[TBL] [Abstract][Full Text] [Related]
37. A comparison of screening tools for the assessment of mild cognitive impairment: preliminary findings.
Ahmed S; de Jager C; Wilcock G
Neurocase; 2012; 18(4):336-51. PubMed ID: 22044211
[TBL] [Abstract][Full Text] [Related]
38. Converting MMSE to MoCA and MoCA 5-minute protocol in an educationally heterogeneous sample with stroke or transient ischemic attack.
Wong A; Black SE; Yiu SYP; Au LWC; Lau AYL; Soo YOY; Chan AYY; Leung TWH; Wong LKS; Kwok TCY; Cheung TCK; Leung KT; Lam BYK; Kwan JSK; Mok VCT
Int J Geriatr Psychiatry; 2018 May; 33(5):729-734. PubMed ID: 29292529
[TBL] [Abstract][Full Text] [Related]
39. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.
Godefroy O; Fickl A; Roussel M; Auribault C; Bugnicourt JM; Lamy C; Canaple S; Petitnicolas G
Stroke; 2011 Jun; 42(6):1712-6. PubMed ID: 21474808
[TBL] [Abstract][Full Text] [Related]
40. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
